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Microelectrode arrays (MEAs) are widely used to assess the electrophysiology of human pluripotent stem cell-derived cardiomyocytes (hPS-CMs).
Traditionally, MEAs have been used to record data at the cell population level, but it would be beneﬁcial to be able to analyze also at the single-cell
level using MEAs. To realize this, we present a special MEA platform for recording ﬁeld potential from single beating cardiomyocytes. The size and
location of transparent indium tin oxide (ITO) electrodes have been optimized to make noninvasive studies of the electrophysiological activity of
cardiomyocytes at the single-cell level possible and also to enable simultaneous video imaging through transparent electrodes and thus image-
based analysis of the mechanical beating behavior of the same cardiomyocytes. Because of these characteristics, this novel platform provides a
powerful tool for assessing the functionality of cardiomyocytes in basic cardiac research, disease modeling, as well as drug development and
toxicology. © 2018 The Japan Society of Applied Physics
1. Introduction
Microelectrode arrays (MEAs) provide a valuable tool for
studying the electrophysiology of cells. In addition, they
provide a platform for long-term and on-line assessment
of electrophysiological parameters at the baseline as well
as during pharmacological or mechanical stress. MEAs
have been widely used for assessing the electrical activity
of multiple cell types, such as human stem cell-derived
cardiomyocytes (hPS-CMs) and neurons at the cell popula-
tion level.1–4)
Human induced pluripotent stem (iPS) cells are derived
from somatic cells with a deﬁned set of factors.5) They can be
diﬀerentiated, e.g., into cardiomyocytes (CMs) by multiple
methods, such as using deﬁned growth factors or small
molecules, or by co-culturing with mouse endodermal-like
(END-2) cells.6,7) With the diﬀerentiation methods, all
cardiac subtypes (pacemaker, atrial, and ventricular cells)
can be produced and the diﬀerentiated hPS-CMs resemble the
native human counterparts in their gene and protein expres-
sion as well as functional properties. Therefore, they are
suitable for modeling human cardiomyocytes and use in
studies of human heart development, cardiac function, and
diseases as well as in drug development and toxicology, as
reviewed earlier.8) hPS-CMs have been used in the evaluation
of cardiac safety of new drug candidates especially for their
eﬀects on the ﬁeld potential duration (FPD), which is
analogous to the QT interval of electrocardiography (ECG).9)
The electrophysiological characteristics of single hPS-CMs
can be assessed using the patch clamp technique and calcium
(Ca2+)- and voltage-sensitive dyes. The patch clamp tech-
nique is a gold standard for the assessment of cardiomyocyte
action potential. However, it is labor-intensive and has a low
throughput and therefore not suitable for high-throughput-
type early-stage drug screening studies. Ca2+- and voltage-
sensitive dyes are suitable for intermediate-throughput-type
studies of cardiomyocyte electrophysiology at the single-
cell and cell population levels and can be used in preclinical
drug testing approaches. However, all these aforementioned
methods are either invasive or toxic to the cells and thus,
long-term experiments are not applicable.
MEAs have been a widely used for assessing electrical
activity and signal propagation as well as the conduction
velocity of hPS-CMs.10–12) hPS-CM measurements using
conventional MEAs consisting of 30 µm electrodes and
200 µm pitch have been limited to cell clusters or mono-
layers; therefore, signals are gained from a cell population.
However, similar to single-cell transcriptomic and proteomic
studies, analyses of the electrophysiological characteristics
using individual cells would produce a more accurate
representation of the cells than bulk measurements.
There is no fundamental reason why conventional MEAs
are not applicable to single-cell studies. However, owing to
the relatively small electrode size, the noise level is high and
the signal amplitude of a single cardiomyocyte is low. Thus,
detecting signals from single cells by conventional MEAs is
very challenging. An additional diﬃculty is getting the single
cells on the electrodes in a conventional layout. Using con-
ventional MEAs, we have not been able to detect signals
from single cells, and to the best of our knowledge there have
been no reports of studies of the electrical activity of single
hPS-CMs using traditional MEAs. Because of these reasons,
performing single-cell studies using conventional MEAs
is not feasible; thus, the single-cell-optimized MEAs were
produced.
By assessing the electrophysiology or calcium transients of
cardiomyocytes, the cardiac function is only measured partly
while ignoring the biomechanics of the actual contraction
of the cardiomyocytes. Previously, the biomechanics of the
cardiomyocyte contraction have been assessed in vitro by
atomic force or traction force microscopy.13,14) However,
recent video microscopy methods have proven to provide a
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relatively simple and noninvasive alternative to studying the
biomechanics of cardiac contraction.15–18) In a recent work,
a video microscopy method was utilized, based on digital
image correlation (DIC) and more speciﬁcally on its subtype,
the minimum quadratic diﬀerence (MQD) method, which
has been developed mainly for particle image velocimetry
(PIV).16) The video microscopy method quantiﬁes the
biomechanics, i.e., the movement of CMs in a noninvasive
and label-free manner, enabling high-throughput-type screen-
ing, as well as long-term measurements.15–17) Video analysis
reveals information on the motion of CMs and, recently,
video microscopy has also been combined with Ca2+
imaging.19) By combining ionic and contraction data, a
deeper understanding of the electromechanical coupling of
cardiomyocyte contraction will be gained and new insights
into cardiac diseases and drug eﬀects may be revealed.
The aim of this study was to produce a MEA platform that
contains electrodes that can measure the electrophysiological
parameters of single hPS-CMs. The platform is designed for
cell cultures where single hPS-CMs are plated on a MEA
plate and only one cell is attached on the electrode. Owing
the transparency of the electrodes, the platform also enables
simultaneous measurement of the electrophysiological and
biomechanical parameters of the contraction of single hPS-
CM contraction noninvasively. The proposed platform con-
sists of transparent electrodes, which are larger than those
in conventional MEA platforms. In addition, the electrode
layout is optimized for hPS-CMs. The custom-made MEA
platforms are used with a conventional MEA ampliﬁer, and
the transparent electrodes enable simultaneous imaging and
video analysis of the hPS-CMs. Therefore, the proposed
approach provides data on both electrophysiological and
biomechanical characteristics of a single cardiomyocyte,
which will be utilized in studies of, e.g., iPS-based genetic
cardiac disease modeling.
2. Materials and methods
2.1 MEA design, fabrication, and characterization
In measuring the ﬁeld potential from a single cell with a
MEA, there are two main challenges: how to 1) place a cell to
be suﬃciently close to the electrode and 2) optimize the
signal-to-noise ratio by adjusting the size of the electrodes. If
the electrode is much larger than the cell, the signal-to-noise
ratio becomes small. However, too small electrodes possess a
higher noise level by nature because impedance and noise are
inversely dependent on the electrode area. For these reasons,
the ﬁeld potential signals of single cardiomyocytes are
diﬃcult to separate from noise. With the conventional MEAs
having ∼30-µm-diameter electrodes with ∼200 µm spacing, it
has been impossible to assess the electrical characteristics of
hPS-CMs at the single-cell level.
The aim of this study was to design a MEA electrode
layout that simultaneously increases the probability of cells to
be located in optimal proximity to the electrodes and provides
suﬃcient signal-to-noise ratio. In Layout 1, the cell culture
area is covered by long and narrow electrodes resembling
ﬁnger electrodes [Fig. 1(a)] to fulﬁll especially the ﬁrst
requirement for a design. For Layout 2 [Fig. 1(b)], we focus
on evaluating diﬀerent electrode sizes and shapes. The elec-
trodes are circular or oval in shape, with some being split into
halves or quarters. In this layout, the electrodes are located
throughout the cell culture area. In Layout 3 [Figs. 1(c) and
1(d)], circular electrodes having a diameter of 80 µm are
placed around the perimeter of the cell culture area. The
center-to-center distance of the electrodes varies from 250 to
460 µm. Some of the electrodes have stripes or round holes
to provide topography, which aims to orientate the cells or
induce the cells to attach to the electrodes. Again, some of
the electrodes are divided into separate halves as in Layout 2.
2.2 MEA fabrication
Figures 2(a)–2(k) show the fabrication process for Layout 3
in detail. The MEAs in Layouts 1 and 2 were fabricated using
mostly the same process as that for MEAs in Layout 3. Two
diﬀerent versions of MEAs having Layout 3 were fabricated;
one with opaque titanium (Ti) electrodes20) and the other with
transparent indium tin oxide (ITO) electrodes. The processing
of MEAs with Ti electrodes started by e-beam deposition of
400 nm of Ti on 49 × 49 × 1mm3 soda lime glass substrates
(Gerhard Menzel). Next, a positive photoresist (Futurrex
PR1-2000A) was used as an etching mask in wet etching the
MEA layout on the Ti layer. In the case of MEAs with ITO
electrodes, a ∼180 nm, 8–10Ω=sq ITO layer was readily
deposited on 49 × 49 × 0.7mm3 boro-aluminosilicate glass
substrates (Universitywafer). In that case, the in-house proc-
ess was started by lift-oﬀ patterning Ti alignment marks on
the ITO-coated substrates. Next, a positive photoresist was
used as an etching mask in etching the MEA layout on the
ITO layer using argon in a reactive-ion etching (RIE) process.
The remaining process steps were the same for the Ti and
ITO versions. A 500 nm Si3N4 layer was deposited by
plasma-enhanced chemical vapor deposition (PECVD) as the
insulator layer and openings for electrodes and contact
pads were dry-etched with a positive photoresist as an etching
mask. Before 400 nm of titanium nitride was deposited by
ion-beam-assisted e-beam deposition (IBAD),21) to protect
the contact pads, the electrode area was covered with a drop
of photoresist. Finally, lift-oﬀ and resist removal were carried
out using acetone in an ultrasound bath. Photolithography
masks used in this work were fabricated in-house using
a µPG501 maskless exposure system (MED; Heidelberg
Instruments Mikrotechnik) on chrome mask blanks (Clean
Surface Technology). In the case of Layout 1, part of the
Fig. 1. (Color online) (a) Electrode Layout 1, (b) Layout 2, and
(c) Layout 3. The black circles represent the central opening in the PDMS
ring; diameters, 2mm in Layouts 1 and 2, and 3.5mm in Layout 3.
(d) 5× microscopy image of Layout 3 MEA. (e) Specially designed
PDMS ring on layout 3 ITO MEA. At the center there is an opening for
microelectrodes and two bigger openings for ground electrodes. The
right-angled ground electrode on the left was used in this study.
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exposures were, however, direct exposures using µPG501
instead of a mask aligner and the chrome masks.
2.3 MEA characterization
In order to characterize the impedance of the electrodes,
a poly(dimethylsiloxane) (PDMS) ring was attached on top
of the ready-made MEAs as a pool and was ﬁlled with
Dulbecco’s phosphate-buﬀered saline (PBS Dulbecco w=o
Ca++, Mg2+, Biochrom) one day before the impedance meas-
urements. The measurement system consisted of an Iviumstat
potentiostat and multiplexers (Ivium Technologies), an
MEA adapter (Multi Channel Systems MCS), and a Pt
wire counter electrode (ALS-Japan). In addition, DRIREF-2
(World Precision Instruments) was used as the reference elec-
trode for single-frequency measurements, where the impe-
dance was measured at 1 kHz frequency. The result for both
electrode types (ITO and Ti) is presented as the average of
the median of 10 randomly selected nonpatterned electrodes
from three MEAs. The impedance was characterized in more
details for a randomly selected electrode over a frequency
range from 1 to 100 000 kHz.
The simple PDMS rings used in the impedance meas-
urements were removed and a specially designed PDMS
ring was applied to the MEAs [Fig. 1(e)] providing small
openings for the electrode area (2.0mm in diameter for
Layouts 1 and 2, and 3.5mm in diameter for Layout 3) and
for the ground electrodes (4mm in diameter). The purpose of
the PDMS ring is to restrict the cell culture area to enhance
the cell attachment to the top of the electrodes and to prevent
the cells from spreading out across the well, e.g., to the
ground electrodes, where the beating of the cells would
disturb the measurement by causing “reversed” signals to
all of the electrodes. The silicone ring also provides a large
reservoir for culture medium (1.5ml). Silicone rings were
fabricated as described previously.22)
Before plating hPS-CMs, the baseline noise was recorded in
the cell culture medium consisting of KnockOut Dulbecco’s
modiﬁed Eagle’s medium (KO-DMEM; Lonza), 20% fetal
bovine serum (FBS; Lonza), 1% nonessential amino acids
(NEAA; Cambrex), 2mM Glutamax (Invitrogen), and 50
U=ml penicillin=streptomycin (Lonza) for 30 s with an
MEA2100 MEA system (MCS). The average root mean
square (RMS) noise level was calculated for each MEA and
MEA type. Electrodes having an RMS noise level above
10 µV were considered faulty and were excluded from the
calculations.
2.4 Cell culture and diﬀerentiation of hPS-derived
cardiomyocytes
The human patient-speciﬁc iPSC line UTA.04602.WT
was used in this study. The iPS cell line has been established
from the ﬁbroblasts of a healthy individual and cultured as
described previously.5,23)
Diﬀerentiation of human pluripotent stem cells into
cardiomyocytes was carried out via temporal modulation
of canonical Wnt-signaling.6) The diﬀerentiated cells were
dissociated into single cells with collagenase A (Roche
Diagnostics).7) Single cells were suspended into the cell
culture medium described above.
The MEA wells were ﬁrst hydrophilized with FBS and
then coated with 0.1% gelatin type A (Sigma-Aldrich).
Immediately after coating, dissociated hPS-CMs were plated
on each MEA by pipetting 50 µl of cell suspension consisting
approximately 200–300 cells to the electrode area. The
hPS-CMs were incubated in this volume of the medium for
1 h in an incubator to let the cells attach to the MEA. After
incubation, the MEA was carefully ﬁlled with 1ml of the cell
culture medium described above. The medium was replaced
with a fresh one for the MEAs every three days, and the
MEAs were measured one day after the medium replacement.
2.5 Cell measurements and data analysis
Field potential (FP) was recorded 5–11 days after plating
at 37 °C, and signals were recorded for 30 s. The sampling
frequency was 20 kHz. Field potential was recorded during
spontaneous baseline beating and after adding 50–100 nM
E-4031 (Sigma-Aldrich) to the cell culture medium. The
E-4031 solution was incubated 2min before the measure-
ments. The E-4031 solution was diluted and measurements
performed in the cell culture medium as described above.
FP data were converted from the MCD format to Axon
Binary File (ABF) using MC_DataTool software (MCS), and
the ABF tile was converted to Axon Text File (ATF) using
ClampFit version 10.3.0.2 (Molecular Devices). The FP
signals in the ATF format were analyzed with an in-house-
developed analysis module using Origin 2017 (Microcal
OriginTM). Beating frequency by beats per minute (BPM),
interbeat interval (IBI), and ﬁeld potential duration (FPD)
were extracted from the data. Bazett’s formula was used to
calculate the beat-rate-corrected FPD (cFPD).
The beating hPS-CMs on MEA chambers were imaged
with a Zeiss Axio Observer-inverted phase contrast micro-
scope and videos were taken with an Imperx Bobcat-camera
Fig. 2. (Color online) (a–k) MEA fabrication process. (a) Glass substrate
coated with ITO or Ti, (b, g) spin coating with photoresist, (c, h) UV exposure
of photoresist, (d, i) developed resist pattern, (e) electrode and track pattern
dry etched to ITO or Ti, (f) PECVD of Si3N4, ( j) dry etching openings for
electrodes, and (k) removal of photoresist. Steps to fabricate alignment marks
for ITO MEA and deposition of TiN to protect contact pads are excluded for
simplicity. (l) Cardiac cell on MEA electrode. Owing to the edges formed by
the Si3N4 insulator layer, the electrode is in a small pit, which may be favored
by the cells. The dimensions in the drawing are not in scale.
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and JAI-Tool software. Videos were recorded for 30 s at 60
frames per second using 20× magniﬁcation. Video and MEA
recordings were taken manually at the same time; therefore,
the recordings were not automatically synchronized in this
study.
The recorded videos were analyzed with CellVisus soft-
ware (BioMediTech), which uses the digital image corre-
lation (DIC)-based analysis method as used previously for
hPS-CMs.16,24) From the videos, the average parameters
of the biomechanics of the contraction were deﬁned: (1)
duration of contraction, (2) time when hPS-CMs contracted,
(3) duration of relaxation, (4) incomplete relaxation time, and
(5) time when the cells relaxed.
For immunocytochemical staining, the hPS-CMs on MEA
chambers were ﬁxed with 4% paraformaldehyde (PFA;
Sigma-Aldrich). The hPS-CMs were stained with a goat
anti-cardiac-troponin-T (anti-Tnt; 1:2000, Abcam) antibody
and incubated at +4 °C overnight. Alexa Fluor 568-con-
jugated polyclonal IgG (Abcam) for the goat anti-Tnt
antibody was used as the secondary antibody and incubated
with the cells for 1 h at room temperature. Cells were mounted
with Vectashield containing 4A,6-diamidino-2-phenylindole,
difydrochloride (DAPI) for staining nuclei (Vector Labs
Vectashield). Fluorescence was visualized using an Olympus
IX51 phase contrast microscope equipped with ﬂuorescence
optics and recorded with an Olympus DP30BW camera. The
images were processed with Image-J and Adobe Photoshop
7.0 software (Adobe Systems).
3. Results and discussion
3.1 MEA layout development and technical
characterization
In Layout 1, the cells plated on the MEA attached to the
electrodes with high probability as the ﬁnger-type electrodes
ﬁlled most of the cell culture area. Unfortunately, the area
where the hPS-CM crossed the electrode was very small
compared with the total electrode size and the signal from the
cell was overpowered by the noise. However, one cardio-
myocyte was found to attach to a circular 100 µm electrode
included for the process characterization reasons. From that
electrode, we were able to measure the signal and obtain a
preliminary proof that a single hPS-CM is measurable by the
MEA if the electrode size is increased from the conventional
size of 30 µm (data not shown).
With MEAs in Layout 2, cardiomyocyte signals were
detectable from some of the electrodes. However, it was
observed that a notable proportion of the plated hPS-CMs
tended to attach to the edges of the cell culture area, near the
PDMS ring. On the basis of this ﬁnding, all the electrodes
in Layout 3 were placed on the outer perimeter of the cell
culture area of the MEA in order to increase the probability
of the cells to attach to the electrodes. With this approach, a
larger number of electrodes provided a signal. Nevertheless,
no signiﬁcant diﬀerences between the electrodes with stripes
or holes and the plain electrodes were observed.
The impedances of ITO and Ti electrodes in Layout 3 were
approximately 250 and 190 kΩ, respectively. The average
baseline RMS noise in contrast was the same (5.4 ± 0.9 µV)
for both materials. The phase and the magnitude of the
impedance of a randomly selected round ITO electrode in a
Layout 3 MEA are shown in Fig. 3 as functions of frequency.
Compared with the standard 30 µm electrodes made of
porous low-impedance materials such as titanium nitride
(TiN) or platinum black, the impedances of our 80 µm ITO
and Ti electrodes were 5–10 times higher despite their clearly
larger sizes. Thus, one future development step in order to
decrease impedance and noise level could be coating the Ti
electrodes with TiN or with platinum black, as was done in a
recent single-cell MEA approach in Ref. 29. These coatings,
however, result in opaque electrodes. In contrast, decreasing
the impedance of transparent ITO electrodes without losing
their transparency is more challenging. Some improvement
could be gained by increasing ITO thickness. However,
because the impedance of the electrode–cell=medium inter-
face dominates over track resistance, a more notable
improvement requires new approaches, such as the develop-
ment of new transparent electrode materials. Nevertheless,
owing to the larger electrode size, the impedance was already
5–10 times smaller than the typical impedance of 30 µm
electrodes made of ITO or Ti.25) The baseline noise levels of
both electrode types werethe same as those of commercial
30 µm TiN electrodes we previously measured for.25) In
addition to noise level and impedance, the material selection
aﬀects also the stimulation capability of the electrodes, which
would enable, e.g., the pacing of hPS-CMs. That is however,
left for future studies.
3.2 Cell attachment and measurements
The speciﬁc aim of this study was to grow no more than one
hPS-CM on one electrode [Fig. 2(l)]. Therefore, the cell
suspension was diluted and the total number of hPS-CMs
plated on MEA plates was low, approximately 200–300
cells=well. The cells attached to the MEA plates during an
overnight incubation and stayed attached as well as func-
tional for at least two weeks on the MEA chambers. The hPS-
CMs were beating and, therefore, functional when cultured in
contact with the opaque Ti electrodes as well as transparent
ITO electrodes.
The electrical activity of all the beating hPS-CMs attached
to the top of the opaque and transparent electrodes in Layout 3
MEAs was detectable (4 MEA chambers used, 1–4 signals
from each chamber observed). The signals were measured
5–11 days after the cell plating. The signal was very clear;
therefore, the beating rate, beat-to-beat interval, and FP dura-
tion were measurable (Fig. 4, Table I). The signal character-
Fig. 3. (Color online) Phase and magnitude of impedance of a randomly
selected round ITO electrode from a Layout 3 MEA as a function of
frequency.
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istics were comparable to those obtained from hPS-CM
aggregates cultured using commercial MEA plates as reported
previously.16,23) In addition to the baseline data, the eﬀects of
the hERG-blocker E-4031 agent known to prolong the FPD
interval were investigated. Prolongation of the FPD interval
was detected at the single-cell level (Fig. 5 and Table I)
Fig. 4. (Color) (a–f) Immunocytochemical characterization of the cells plated on MEA chamber. (a) A MEA chamber with transparent electrodes and with
DAPI staining indicating cell nuclei. (b) Insert in (a), indicating that both of the electrodes numbered 77 and 87 have one cell on each. (c) Immunocytochemical
staining with cardiac-speciﬁc anti-troponin T antibody reveals that both of the cells on the electrodes are cardiomyocytes (indicated by arrows). (d) MEA
chamber with opaque electrodes. (e) DAPI-stained nuclei are not visible on the electrodes with the inverted microscope if there are no holes on the electrode
area, as on electrode 74. (f) Anti-troponin antibody staining shows that the cell on electrode 74 is a cardiomyocyte. (g–h) MEA signal (blue) aligned with the
biomechanical signal of the contraction (red) analyzed by the video microscopy method from the hPS-CMs plated on the transparent electrodes. With both of
the methods, a clear signal was obtained. (i) MEA signal gained from the hPS-CM on the opaque electrode.
Table I. Representative examples of the parameters describing the electrophysiology and biomechanics of the cardiac contraction of hPS-CM measured
from the single hPS-CMs (Cells 1–6). The BPM and IBI gained from MEA and video data are comparable. With the single-cell MEA, the expected FPD
prolonging eﬀect of the the K+-channel blocker E-4031 is observed. BPM, beats per minute; IBI, beat-to-beat interval; FPD, ﬁeld potential duration; cFPD,
corrected ﬁeld potential duration.
MEA data Biomechanical (video) data
BPM
IBI
(ms)
FPD B
(ms)
cFPD B
(ms)
BPM
IBI
(ms)
Duration of mechanical activity
(ms)
Cell 1 Baseline 38 1599 1055 834 38 1598 721
Cell 2 Baseline 17 3583 2623 1386 17 3461 1333
Cell 3 Baseline 93 644 480 598 94 639 164
Cell 4 Baseline 75 804 604 673 74 818 352
E-4031 54 1112 829 786 N=A N=A N=A
Cell 5 Baseline 18 3426 1563 844 N=A N=A N=A
E-4031 13 4508 1821 858 N=A N=A N=A
Cell 6 Baseline 62 965 702 714 N=A N=A N=A
E-4031 48 1262 825 735 N=A N=A N=A
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demonstrating successfully the possibility of pharmaceutical
testing on this novel single-cell MEA platform.
Owing to the transparency of the electrodes, the plated
hPS-CMs could be imaged with the inverted phase contrast
microscope. The videos of the hPS-CMs plated on the elec-
trodes were analyzed by the Cell Visus software and the
results of the analysis were comparable to the MEA data
produced with the single-cell MEA system (Fig. 4, Table I,
and video 1 in the online supplementary data at http://
stacks.iop.org/JJAP/57/117001/mmedia). The obtained beat-
ing frequencies and beat-to-beat intervals were similar when
recorded with the two methods.
The results showed that the MEA platform we devel-
oped can simultaneously record electrophysiological and
biomechanical data and can thus be used for studies of
cardiomyocyte function at the single-cell level owing to the
transparency of the electrodes. Therefore, with this method,
we can assess, e.g., the electromechanical coupling of hPS-
CMs,16) which provides a valuable tool for evaluating, for
example, the proarrhythmic risk of novel drug candidates.
However, the correlation between the electrical and mechani-
cal functions of single hPS-CMs will be assessed in detail in
future studies, since it is not within the scope of this study.
The beating was also observed from the opaque electrodes
possessing gaps or holes (video 2 in the online supplemen-
tary data at http://stacks.iop.org/JJAP/57/117001/mmedia).
However, video analysis was not possible and the contraction
parameters could not be assessed. Therefore, to obtain both
the MEA and video data, we concluded that the electrodes
have to be transparent.
In this study, the entire cell culture area was coated with
gelatin to support cell attachment. To increase the number of
single cells attached on single electrodes, one possibility is
the selective patterning of the electrodes with gelatin or other
extracellular matrix proteins.26) Recently, three-dimensional
(3D) printing technologies have been applied to the genera-
tion of 3D cardiac patches composed of hPS-CMs and other
supporting cell types with and without biomaterials.27,28)
Therefore, cell printing is an intriguing method that can be
utilized also in the present single-cell MEA application, as
the printer could print the cells exactly on the electrodes.
Recently, Kaneko et al.29) have proposed a MEA layout with
small 8-µm-diameter and 1.4–3.0-µm-thick opaque platinum-
black electrodes and agarose microchambers, where single
CMs were seeded individually with a micropipette. With this
method, the extracellular potential of a single CM was deter-
mined. However, the approach suﬀered from cell handling
issues as well as diﬃculties with detecting two phases of FP
peaks. We found the electrode diameter of 80 µm to be large
enough to house a cell and to increase the probability of cell
attachment compared with the standard 30 µm electrodes.
Moreover, the diameter is suﬃciently small to distinguish the
cell signal from the background noise.
4. Conclusions
In this study, we introduced a MEA platform for assessing
the electrophysiological characteristics (including FPD, beat-
ing frequency and beat-to-beat interval) of the hPS-CMs
at the single-cell level. In addition, the transparency of the
electrodes enables simultaneous video recording and analysis
of the biomechanics of hPS-CM contraction and thus,
enabling simultaneous electrophysiological and biomechan-
ical characterization. With the video analysis, the durations
of contraction and relaxation can be evaluated in addition to
the alterations in the beating behavior such as a prolonged
contraction or relaxation and oscillations in the beating.16,24)
The simultaneous electrophysiological and biomechanical
characteristization provides a valuable tool for iPS-based
disease modeling, as well as toxicology and drug develop-
ment. In addition, the noninvasive nature of the novel
platform enables the long-term assessment of the function-
ality of hPS-CMs at the baseline as well as the short- and
long-term eﬀects of alteration to putative drug agents. This
platform opens up a new gateway to modeling cardiac
diseases including genetic diseases and ischemia at the
single-cell level.
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